CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
High ImpactOriginal article

Merck beats AstraZeneca to first approval for first PCSK9 pill

RegulatoryapprovedPositive
AI Analysis

Summary

Merck has achieved the first US approval for an oral PCSK9 inhibitor, beating AstraZeneca in the competitive race to bring this cholesterol-lowering medication to market in pill form.

Outcome Details

First US approval for oral PCSK9 inhibitor

Importance:8/10
Sentiment:
0.75
FDA approvalPCSK9 inhibitorOral formulationCompetitive win
Related Companies

Read the original article

Published by Endpoints News on July 16, 2026 10:45 AM

Read Original